A new study by McGill University professor of psychology Dr. Jeffrey Mogil shows that the capacity for empathy, previously suspected but unproven even among higher primates, is also evident in lower mammals.
Related stories:
Medicines derived from cannabis: a review of adverse events
Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events.
World first: researchers develop completely automated anesthesia system
Researchers at McGill University and the McGill University Health Centre (MUHC) have performed the world’s first totally automated administration of an anesthetic. Nicknamed “McSleepy,” the new system developed by the researchers administers drugs for general anesthesia and monitors their separate effects completely automatically, with no manual intervention.
Pretermers bounce back from pain with a cuddle
Research published today in the open access journal
BMC Pediatrics suggests that very preterm babies, born between 28 and 31 weeks, could benefit from skin-to-skin cuddling with their mother before and during painful procedures such as a heel lance.
Popular osteoporosis drugs triple risk of bone necrosis
A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain.
Study: cannabis a double-edged sword
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses. However, at higher doses, the effect reverses itself and can actually worsen depression and other psychiatric conditions like psychosis.
Counseling, coping skills could reduce arthritis disability
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review.
Study: Vioxx poses even short-term risks
A Montreal study raises questions about even short-term use of the pain drug Vioxx and may harm Merck & Co.'s defense against 11,500 lawsuits, a report said.
New drug acts as marijuana in the brain
A McGill University study suggests a new anti-depressant drug works by raising levels of endocannabinoids -- similar to a substance found in marijuana.